Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion
Cindy C Y Law(Massachusetts General Hospital), Takayuki Yamamoto(Yokkaichi Social Insurance Hospital), Péter L. Lakatos(McGill University), Remo Panaccione(University of Calgary), Maia Kayal(Icahn School of Medicine at Mount Sinai), Jean‐Frédéric Colombel(Mount Sinai Hospital), Rupert W. Leong(The University of Sydney), Phillip Fleshner, Virginia Solitano(Western University), Ryan C. Ungaro(Feinstein Institute for Medical Research), Torsten Kucharzik(Klinikum Lüneburg), Raja Atreya(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ferdinando D’Amico(Humanitas University), Siddharth Singh(Mayo Clinic in Arizona), Richard B. Gearry(Waitaki Biosciences (New Zealand)), Neeraj Narula(McMaster University), Julián Panés(Hospital Clínic de Barcelona), Ailsa Hart(St Mark's Hospital), Christopher Ma(University of Calgary), Matthieu Allez(Inserm), Fernando Magro(Universidade do Porto), Geert D’Haens(Amsterdam University Medical Centers), Tim Raine(National Health Service), Brian Bressler(University of British Columbia), Édouard Louis(Centre Hospitalier Universitaire de Liège), Alice C. Levine(Icahn School of Medicine at Mount Sinai), Simon Travis(University of Oxford), Jurij Hanžel(University of Ljubljana), Andrea Delgado-Nieves(Icahn School of Medicine at Mount Sinai), Benjamin L. Cohen(Cleveland Clinic), A. Hillary Steinhart(Mount Sinai Hospital), Miguel Regueiro(University of Pittsburgh Medical Center), Silvio Danese, Elizabeth A. Spencer(Icahn School of Medicine at Mount Sinai), Shivani Seth(Icahn School of Medicine at Mount Sinai), Stephen B. Hanauer(Northwestern University), Axel Dignaß, Laurent Peyrin-Biroulet(Inserm), Zhihua Ran, Peter Bossuyt(Imelda Hospital), Bruce E Sands, Marla Dubinsky(Cedars-Sinai Medical Center), Vaibhaw Kumar, Charles N. Bernstein(University of Manitoba), Natalia Viera-Feliciano(Mount Sinai Health System), Robert V. Bryant(Queen Elizabeth Hospital), Walter Reinsch, Rachel Sheskier(Mount Sinai Health System)
Cited by 3
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k